Jue Pu
Direttore/Membro del Consiglio presso LEPU BIOPHARMA CO., LTD.
Patrimonio netto: 59 M $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Eric Rowinsky | M | 67 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 9 anni |
| Ambaw Bellete | M | 54 | 1 anni | |
| De Min Zhou | M | 58 | 4 anni | |
| Ziye Sui | M | - | 4 anni | |
| Saeed Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 14 anni |
| Yun Yi Li | F | 44 | 4 anni | |
| Hai Feng Yang | M | 47 | 4 anni | |
| Victor Tong | M | 41 | 1 anni | |
| Zhong Jie Pu | M | 61 | 6 anni | |
| Feng Mao Hua | M | 56 | 3 anni | |
| Brian Liu | M | 36 | 2 anni | |
| David Mangelsdorf | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
| peter vlasselaer | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 6 anni |
| Maggie Geman Li | F | 58 | 4 anni | |
| Hu Li | M | 59 | 4 anni | |
| Lei Fang | M | 41 | 4 anni | |
| Vijay Kasturi | M | 57 | 1 anni | |
| Min MIn Qin | M | 66 | 4 anni | |
| Tess Hau | F | - |
Stanford University
| 12 anni |
| Raymond Camahort | M | 45 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 3 anni |
| Hongbing Yang | M | 55 | 4 anni | |
| Jiwei Wang | M | 37 | 4 anni | |
| Nancy T. Chang | M | 74 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
| Ming Yang | M | 58 | 4 anni | |
| Dieter Weinand | M | 63 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 3 anni |
| Siu Kuen Lai | F | 48 | 3 anni | |
| Nilesh Kumar | M | 47 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
| Yang Xu | M | 57 | 4 anni | |
| Usman Azam | M | 55 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 1 anni |
| Peter van Vlasselaer | M | 64 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 6 anni |
| Antoine Papiernik | M | 56 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
| Swapnil Bhargava | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Masoud Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 13 anni |
| Steven Kozhimala | M | - |
The Wharton School of the University of Pennsylvania
| 10 anni |
| Pranav Gupta | M | - |
The Wharton School of the University of Pennsylvania
| 13 anni |
| Peter Moran | M | - |
Stanford University
| 4 anni |
| Emily Janvey | M | - |
The Wharton School of the University of Pennsylvania
| 5 anni |
| Yi Peng Li | M | 47 | - | |
| Sapna Tejwani Jethwa | F | - |
The Wharton School of the University of Pennsylvania
| 11 anni |
| Raakhe Kapoor Tandon | F | - |
The Wharton School of the University of Pennsylvania
| 5 anni |
| Eli Simon | M | - |
The Wharton School of the University of Pennsylvania
| 5 anni |
| Greg Kress | M | - |
Stanford University
| 5 anni |
| Haomiao Huang | M | - |
Stanford University
| 7 anni |
| Neel Murthy | M | - |
Stanford University
| 6 anni |
| Vandit D. Shah | M | - |
The Wharton School of the University of Pennsylvania
| 3 anni |
| Steven Finn | M | 38 |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Kristen Wong | F | - |
Stanford University
| 4 anni |
| Sydney Werber | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Chao Hong Hu | M | 58 | 4 anni | |
| Xiaohan Zhu | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Edward Segal | M | - |
Stanford University
| 4 anni |
| Eric Sun | M | - |
The Wharton School of the University of Pennsylvania
| 11 anni |
| Christine Black | F | - |
The Wharton School of the University of Pennsylvania
| 10 anni |
| Jing Lin | F | - |
The Wharton School of the University of Pennsylvania
| 8 anni |
| Jennifer Rowland | F | - |
The Wharton School of the University of Pennsylvania
| 5 anni |
| Jordan Moelis | M | - |
The Wharton School of the University of Pennsylvania
| 5 anni |
| Sahil Bloom | M | - |
Stanford University
| 4 anni |
| Rama Sekhar | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| David Bard | M | - |
The Wharton School of the University of Pennsylvania
| 12 anni |
| Stewart Lynn | M | - |
Stanford University
| 5 anni |
| Rashad Rahman | M | - |
The Wharton School of the University of Pennsylvania
| 15 anni |
| Justin Green | M | - |
The Wharton School of the University of Pennsylvania
| 11 anni |
| Chase Beeler | M | - |
Stanford University
| 5 anni |
| Samir Siddhanti | M | - |
Stanford University
| 5 anni |
| Samir Malik | M | - |
The Wharton School of the University of Pennsylvania
| 7 anni |
| Shirin Bohra | F | - |
The Wharton School of the University of Pennsylvania
| 12 anni |
| Rohit Nagpal | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Talal Arij Khan | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Rachel Presser | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Nagendra Jayanty | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Patrick Sullivan | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Dan Harrison | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Peter Gajdos | M | 41 |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Lucia S. Kim | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Charles H. Tingue | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Joel Hwang | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| David Choi | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Eurie Kim | F | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Erin Shipley | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Amy Chang | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Gregory Dabrowski | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Xiang Qian Lin | M | 40 |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Ethan Chung | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Brian Laurence Hinkes | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Edward Chung | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Andrew Fohrer | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Liam Localio | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Brooks Powlen | M | - |
The Wharton School of the University of Pennsylvania
| 3 anni |
| Amy X. Liu | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Jennifer Chen Lai | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Alan Tse | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Andrew Pon | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Kelly Zhou | F | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Jamie Anderson | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Bianca Stoica | F | 31 |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Mohaimin Altaf | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Christian Moore | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Andre Levy | M | - |
The Wharton School of the University of Pennsylvania
| 2 anni |
| Joshua Salzman | M | - |
The Wharton School of the University of Pennsylvania
| 4 anni |
| Thomas Colligan | M | 79 |
The Wharton School of the University of Pennsylvania
| 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 83 | 83.00% |
| Cina | 17 | 17.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jue Pu
- Contatti personali
